Author | Daniella (Dee) Latham

Bio Relief: US FDA Rules On Biosimilars Naming

January 13, 2017

The suspense is over: the US Food and Drug Administration (FDA) has made their decision.

What President Trump Means for Big Pharma

January 12, 2017

Patients may save money on prescriptions---and cut down pharma's profits.

Mylan and Momenta Pharma Combine Biosimilar Forces

January 07, 2017

Mylan and Momenta Pharmaceuticals to develop, manufacture, and commercialize six of Momenta’s current biosimilar candidates.